Back to Search
Start Over
Myotonic dystrophy: approach to therapy.
- Source :
-
Current Opinion in Genetics & Development . Jun2017, Vol. 44, p135-140. 6p. - Publication Year :
- 2017
-
Abstract
- Myotonic dystrophy (DM) is a dominantly-inherited genetic disorder affecting skeletal muscle, heart, brain, and other organs. DM type 1 is caused by expansion of a CTG triplet repeat in DMPK , whereas DM type 2 is caused by expansion of a CCTG tetramer repeat in CNBP . In both cases the DM mutations lead to expression of dominant-acting RNAs. Studies of RNA toxicity have now revealed novel mechanisms and new therapeutic targets. Preclinical data have suggested that RNA dominance is responsive to therapeutic intervention and that DM therapy can be approached at several different levels. Here we review recent efforts to alleviate RNA toxicity in DM. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 0959437X
- Volume :
- 44
- Database :
- Academic Search Index
- Journal :
- Current Opinion in Genetics & Development
- Publication Type :
- Academic Journal
- Accession number :
- 123259371
- Full Text :
- https://doi.org/10.1016/j.gde.2017.03.007